{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:02:00Z","timestamp":1790622120905,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T00:00:00Z","timestamp":1447027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T00:00:00Z","timestamp":1447027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00281-015-0540-2","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T06:05:20Z","timestamp":1447049120000},"page":"75-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Adverse cutaneous drug eruptions: current understanding"],"prefix":"10.1007","volume":"38","author":[{"given":"W.","family":"Hoetzenecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"N\u00e4geli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. T.","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Saulite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Schmid-Grendelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Guenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cozzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. E.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"540_CR1","first-page":"319","volume-title":"Dermatology","author":"LE French","year":"2013","unstructured":"French LE, Prins C (2013) Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Bolognia JL, Jorrizo JL, Schaffer JV (eds) Dermatology, vol 3, 3rd edn. Elsevier, New York, pp 319\u2013334","edition":"3"},{"issue":"4","key":"540_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.mcna.2010.04.001","volume":"94","author":"AJ Bircher","year":"2010","unstructured":"Bircher AJ, Scherer K (2010) Delayed cutaneous manifestations of drug hypersensitivity. Med Clin North Am 94(4):711\u2013725. doi:10.1016\/j.mcna.2010.04.001","journal-title":"Med Clin North Am"},{"issue":"6","key":"540_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/all.12142","volume":"68","author":"K Brockow","year":"2013","unstructured":"Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, Terreehorst I, Group EEDAI (2013) Skin test concentrations for systemically administered drugs\u2014an ENDA\/EAACI Drug Allergy Interest Group position paper. Allergy 68(6):702\u2013712. doi:10.1111\/all.12142","journal-title":"Allergy"},{"key":"540_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/all.12698","author":"HJ Hoffmann","year":"2015","unstructured":"Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, Rouzaire P, Ebo D, Sabato V, Sanz ML, Pecaric-Petkovic T, Patil SU, Hausmann OV, Shreffler WG, Korosec P, Knol EF (2015) The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. doi:10.1111\/all.12698","journal-title":"Allergy"},{"issue":"2","key":"540_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jaci.2014.12.1906","volume":"135","author":"SH Sicherer","year":"2015","unstructured":"Sicherer SH, Leung DY (2015) Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2014. J Allergy Clin Immunol 135(2):357\u2013367. doi:10.1016\/j.jaci.2014.12.1906","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"540_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/cea.12145","volume":"43","author":"G Porebski","year":"2013","unstructured":"Porebski G, Pecaric-Petkovic T, Groux-Keller M, Bosak M, Kawabata TT, Pichler WJ (2013) In vitro drug causality assessment in Stevens-Johnson syndrome\u2014alternatives for lymphocyte transformation test. Clin Exp Allergy 43(9):1027\u20131037. doi:10.1111\/cea.12145","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"540_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjd.12109","volume":"168","author":"ME Polak","year":"2013","unstructured":"Polak ME, Belgi G, McGuire C, Pickard C, Healy E, Friedmann PS, Ardern-Jones MR (2013) In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions. Br J Dermatol 168(3):539\u2013549. doi:10.1111\/bjd.12109","journal-title":"Br J Dermatol"},{"issue":"4","key":"540_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1398-9995.2008.01674.x","volume":"64","author":"A Rozieres","year":"2009","unstructured":"Rozieres A, Hennino A, Rodet K, Gutowski MC, Gunera-Saad N, Berard F, Cozon G, Bienvenu J, Nicolas JF (2009) Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 64(4):534\u2013542. doi:10.1111\/j.1398-9995.2008.01674.x","journal-title":"Allergy"},{"issue":"4","key":"540_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/all.12350","volume":"69","author":"P Demoly","year":"2014","unstructured":"Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, Khan DA, Lang DM, Park HS, Pichler W, Sanchez-Borges M, Shiohara T, Thong BY (2014) International consensus on drug allergy. Allergy 69(4):420\u2013437. doi:10.1111\/all.12350","journal-title":"Allergy"},{"issue":"24","key":"540_CR10","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","volume":"256","author":"M Bigby","year":"1986","unstructured":"Bigby M, Jick S, Jick H, Arndt K (1986) Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. Jama 256(24):3358\u20133363","journal-title":"Jama"},{"issue":"6","key":"540_CR11","first-page":"765","volume":"137","author":"M Bigby","year":"2001","unstructured":"Bigby M (2001) Rates of cutaneous reactions to drugs. Arch Dermatol 137(6):765\u2013770","journal-title":"Arch Dermatol"},{"issue":"3","key":"540_CR12","first-page":"278","volume":"2","author":"S Nigen","year":"2003","unstructured":"Nigen S, Knowles SR, Shear NH (2003) Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol: JDD 2(3):278\u2013299","journal-title":"J Drugs Dermatol: JDD"},{"issue":"5-6","key":"540_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.0105-1873.2004.00445.x","volume":"51","author":"P Hausermann","year":"2004","unstructured":"Hausermann P, Harr T, Bircher AJ (2004) Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 51(5-6):297\u2013310. doi:10.1111\/j.0105-1873.2004.00445.x","journal-title":"Contact Dermatitis"},{"key":"540_CR14","volume-title":"Clinical aspects of immunology","author":"PGH Gell","year":"1963","unstructured":"Gell PGH, Coombs RRA (1963) Clinical aspects of immunology. Blackwell, Oxford"},{"issue":"6","key":"540_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1610-0387.2010.07339.x","volume":"8","author":"K Scherer","year":"2010","unstructured":"Scherer K, Spoerl D, Bircher AJ (2010) Adverse drug reactions to biologics. J Dtsch Dermatol Gesellschaft\u2009=\u2009J German Soc Dermatol: JDDG 8(6):411\u2013426. doi:10.1111\/j.1610-0387.2010.07339.x","journal-title":"J Dtsch Dermatol Gesellschaft\u2009=\u2009J German Soc Dermatol: JDDG"},{"issue":"5","key":"540_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","volume":"157","author":"M Tohyama","year":"2007","unstructured":"Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH (2007) Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 157(5):934\u2013940. doi:10.1111\/j.1365-2133.2007.08167.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"540_CR17","first-page":"770","volume":"57","author":"M Campos-Fernandez Mdel","year":"2005","unstructured":"Campos-Fernandez Mdel M, Ponce-De-Leon-Rosales S, Archer-Dubon C, Orozco-Topete R (2005) Incidence and risk factors for cutaneous adverse drug reactions in an intensive care unit. Revista Investig Clin; Organo Hosp Enferm Nutr 57(6):770\u2013774","journal-title":"Revista Investig Clin; Organo Hosp Enferm Nutr"},{"key":"540_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12591","author":"B Schnyder","year":"2015","unstructured":"Schnyder B, Brockow K (2015) Pathogenesis of drug allergy, current concepts and recent insights. Clin Exp Allergy. doi:10.1111\/cea.12591","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"540_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/archderm.1984.01650400102024","volume":"120","author":"W Korkij","year":"1984","unstructured":"Korkij W, Soltani K (1984) Fixed drug eruption. A brief review. Arch Dermatol 120(4):520\u2013524","journal-title":"Arch Dermatol"},{"issue":"4","key":"540_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/ACI.0b013e32832cda4c","volume":"9","author":"T Shiohara","year":"2009","unstructured":"Shiohara T (2009) Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol 9(4):316\u2013321. doi:10.1097\/ACI.0b013e32832cda4c","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"540_CR21","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0002-9440(10)64410-0","volume":"161","author":"Y Mizukawa","year":"2002","unstructured":"Mizukawa Y, Yamazaki Y, Teraki Y, Hayakawa J, Hayakawa K, Nuriya H, Kohara M, Shiohara T (2002) Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption. Am J Pathol 161(4):1337\u20131347","journal-title":"Am J Pathol"},{"issue":"5","key":"540_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2230.2009.03622.x","volume":"35","author":"Y Mizukawa","year":"2010","unstructured":"Mizukawa Y, Shiohara T (2010) Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses. Clin Exp Dermatol 35(5):493\u2013497. doi:10.1111\/j.1365-2230.2009.03622.x","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"540_CR23","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1365-2133.2008.08516.x","volume":"158","author":"Y Mizukawa","year":"2008","unstructured":"Mizukawa Y, Yamazaki Y, Shiohara T (2008) In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol 158(6):1230\u20131238. doi:10.1111\/j.1365-2133.2008.08516.x","journal-title":"Br J Dermatol"},{"issue":"7","key":"540_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm.3883","volume":"21","author":"CO Park","year":"2015","unstructured":"Park CO, Kupper TS (2015) The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med 21(7):688\u2013697. doi:10.1038\/nm.3883","journal-title":"Nat Med"},{"issue":"7","key":"540_CR25","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","volume":"192","author":"S Cheuk","year":"2014","unstructured":"Cheuk S, Wiken M, Blomqvist L, Nylen S, Talme T, Stahle M, Eidsmo L (2014) Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis. J Immunol 192(7):3111\u20133120. doi:10.4049\/jimmunol.1302313","journal-title":"J Immunol"},{"issue":"279","key":"540_CR26","doi-asserted-by":"publisher","first-page":"279ra239","DOI":"10.1126\/scitranslmed.3010302","volume":"7","author":"R Watanabe","year":"2015","unstructured":"Watanabe R, Gehad A, Yang C, Scott LL, Teague JE, Schlapbach C, Elco CP, Huang V, Matos TR, Kupper TS, Clark RA (2015) Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Trans Med 7(279):279ra239. doi:10.1126\/scitranslmed.3010302","journal-title":"Sci Trans Med"},{"key":"540_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-014-8421-3","author":"T Shiohara","year":"2014","unstructured":"Shiohara T, Ushigome Y, Kano Y, Takahashi R (2014) Crucial role of viral reactivation in the development of severe drug eruptions: a comprehensive review. Clin Rev Allergy Immunol. doi:10.1007\/s12016-014-8421-3","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7388","key":"540_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature10851","volume":"483","author":"X Jiang","year":"2012","unstructured":"Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS (2012) Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity. Nature 483(7388):227\u2013231. doi:10.1038\/nature10851","journal-title":"Nature"},{"issue":"2","key":"540_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nm.2078","volume":"16","author":"L Liu","year":"2010","unstructured":"Liu L, Zhong Q, Tian T, Dubin K, Athale SK, Kupper TS (2010) Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med 16(2):224\u2013227. doi:10.1038\/nm.2078","journal-title":"Nat Med"},{"issue":"3","key":"540_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.immuni.2006.06.019","volume":"25","author":"L Liu","year":"2006","unstructured":"Liu L, Fuhlbrigge RC, Karibian K, Tian T, Kupper TS (2006) Dynamic programming of CD8+ T cell trafficking after live viral immunization. Immunity 25(3):511\u2013520. doi:10.1016\/j.immuni.2006.06.019","journal-title":"Immunity"},{"issue":"12","key":"540_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2133.1967.tb11434.x","volume":"79","author":"A Lyell","year":"1967","unstructured":"Lyell A (1967) A review of toxic epidermal necrolysis in Britain. Br J Dermatol 79(12):662\u2013671","journal-title":"Br J Dermatol"},{"issue":"9171","key":"540_CR32","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","volume":"353","author":"B Rzany","year":"1999","unstructured":"Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R (1999) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 353(9171):2190\u20132194","journal-title":"Lancet"},{"issue":"10","key":"540_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2165\/00002018-200528100-00008","volume":"28","author":"L La Grenade","year":"2005","unstructured":"La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, Brinker A (2005) Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. Drug Saf 28(10):917\u2013924","journal-title":"Drug Saf"},{"issue":"3","key":"540_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1023\/B:NEON.0000014538.31561.bc","volume":"66","author":"D Aguiar","year":"2004","unstructured":"Aguiar D, Pazo R, Duran I, Terrasa J, Arrivi A, Manzano H, Martin J, Rifa J (2004) Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neuro-oncol 66(3):345\u2013350","journal-title":"J Neuro-oncol"},{"issue":"5","key":"540_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1468-3083.2006.01510.x","volume":"20","author":"F Aydin","year":"2006","unstructured":"Aydin F, Cokluk C, Senturk N, Aydin K, Canturk MT, Turanli AY (2006) Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin. J Eur Acad Dermatol Venereol:JEADV 20(5):588\u2013590. doi:10.1111\/j.1468-3083.2006.01510.x","journal-title":"J Eur Acad Dermatol Venereol:JEADV"},{"issue":"12","key":"540_CR36","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s001340050492","volume":"23","author":"F Lebargy","year":"1997","unstructured":"Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, Roupie E, Revuz J, Roujeau JC (1997) Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 23(12):1237\u20131244","journal-title":"Intensive Care Med"},{"issue":"9","key":"540_CR37","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","volume":"123","author":"J Revuz","year":"1987","unstructured":"Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, Touraine R (1987) Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 123(9):1160\u20131165","journal-title":"Arch Dermatol"},{"issue":"2","key":"540_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","volume":"26","author":"YS Chang","year":"2007","unstructured":"Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM (2007) Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26(2):123\u2013129. doi:10.1097\/ICO.0b013e31802eb264","journal-title":"Cornea"},{"issue":"4","key":"540_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","volume":"116","author":"C Sotozono","year":"2009","unstructured":"Sotozono C, Ueta M, Koizumi N, Inatomi T, Shirakata Y, Ikezawa Z, Hashimoto K, Kinoshita S (2009) Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 116(4):685\u2013690. doi:10.1016\/j.ophtha.2008.12.048","journal-title":"Ophthalmology"},{"key":"540_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau J-C (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92\u201396","journal-title":"Arch Dermatol"},{"issue":"5","key":"540_CR41","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","volume":"62","author":"LW Yip","year":"2007","unstructured":"Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ (2007) Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy 62(5):527\u2013531. doi:10.1111\/j.1398-9995.2006.01295.x","journal-title":"Allergy"},{"issue":"1","key":"540_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000070938","volume":"207","author":"S Magina","year":"2003","unstructured":"Magina S, Lisboa C, Leal V, Palmares J, Mesquita-Guimaraes J (2003) Dermatological and ophthalmological sequels in toxic epidermal necrolysis. Dermatology 207(1):33\u201336","journal-title":"Dermatology"},{"key":"540_CR43","doi-asserted-by":"publisher","DOI":"10.1159\/000433423","author":"N Bentele-Jaberg","year":"2015","unstructured":"Bentele-Jaberg N, Guenova E, Mehra T, Nageli M, Chang YT, Cozzio A, French LE, Hoetzenecker W (2015) The phytotherapeutic fenugreek as trigger of toxic epidermal necrolysis. Dermatology. doi:10.1159\/000433423","journal-title":"Dermatology"},{"issue":"13","key":"540_CR44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJM198109243051302","volume":"305","author":"SP Spielberg","year":"1981","unstructured":"Spielberg SP, Gordon GB, Blake DA, Goldstein DA, Herlong HF (1981) Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med 305(13):722\u2013727. doi:10.1056\/NEJM198109243051302","journal-title":"N Engl J Med"},{"issue":"2","key":"540_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","volume":"105","author":"NH Shear","year":"1986","unstructured":"Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W (1986) Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 105(2):179\u2013184","journal-title":"Ann Intern Med"},{"issue":"4","key":"540_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00008571-199508000-00011","volume":"5","author":"P Wolkenstein","year":"1995","unstructured":"Wolkenstein P, Carriere V, Charue D, Bastuji-Garin S, Revuz J, Roujeau JC, Beaune P, Bagot M (1995) A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. Pharmacogenetics 5(4):255\u2013258","journal-title":"Pharmacogenetics"},{"issue":"5","key":"540_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-0625.1995.tb00211.x","volume":"4","author":"A Dietrich","year":"1995","unstructured":"Dietrich A, Kawakubo Y, Rzany B, Mockenhaupt M, Simon JC, Schopf E (1995) Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Dermatol 4(5):313\u2013316","journal-title":"Exp Dermatol"},{"issue":"7","key":"540_CR48","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.4049\/jimmunol.1302306","volume":"192","author":"J Yun","year":"2014","unstructured":"Yun J, Marcaida MJ, Eriksson KK, Jamin H, Fontana S, Pichler WJ, Yerly D (2014) Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01. J Immunol 192(7):2984\u20132993. doi:10.4049\/jimmunol.1302306","journal-title":"J Immunol"},{"issue":"7404","key":"540_CR49","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11147","volume":"486","author":"PT Illing","year":"2012","unstructured":"Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486(7404):554\u2013558. doi:10.1038\/nature11147","journal-title":"Nature"},{"issue":"25","key":"540_CR50","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.1073\/pnas.1207934109","volume":"109","author":"DA Ostrov","year":"2012","unstructured":"Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A 109(25):9959\u20139964. doi:10.1073\/pnas.1207934109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"540_CR51","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 102(11):4134\u20134139","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"540_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","volume":"7","author":"WH Chung","year":"2007","unstructured":"Chung WH, Hung SI, Chen YT (2007) Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 7(4):317\u2013323. doi:10.1097\/ACI.0b013e3282370c5f","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6982","key":"540_CR53","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428(6982):486","journal-title":"Nature"},{"issue":"12","key":"540_CR54","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","volume":"364","author":"P Chen","year":"2011","unstructured":"Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY, Taiwan SJSC (2011) Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 364(12):1126\u20131133. doi:10.1056\/NEJMoa1009717","journal-title":"N Engl J Med"},{"issue":"5388","key":"540_CR55","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282(5388):490\u2013493","journal-title":"Science"},{"issue":"2","key":"540_CR56","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1523-1747.2000.00037.x","volume":"115","author":"P Wehrli","year":"2000","unstructured":"Wehrli P, Viard I, Bullani R, Tschopp J, French LE (2000) Death receptors in cutaneous biology and disease. J Investig Dermatol 115(2):141\u2013148. doi:10.1046\/j.1523-1747.2000.00037.x","journal-title":"J Investig Dermatol"},{"issue":"6","key":"540_CR57","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1365-2230.2004.01635.x","volume":"29","author":"K Ito","year":"2004","unstructured":"Ito K, Hara H, Okada T, Shimojima H, Suzuki H (2004) Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression. Clin Exp Dermatol 29(6):679\u2013680","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"540_CR58","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14(12):1343\u20131350. doi:10.1038\/nm.1884","journal-title":"Nat Med"},{"issue":"245","key":"540_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/scitranslmed.3008227","volume":"6","author":"N Saito","year":"2014","unstructured":"Saito N, Qiao H, Yanagi T, Shinkuma S, Nishimura K, Suto A, Fujita Y, Suzuki S, Nomura T, Nakamura H, Nagao K, Obuse C, Shimizu H, Abe R (2014) An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions. Sci Transl Med 6(245):245","journal-title":"Sci Transl Med"},{"issue":"18","key":"540_CR60","doi-asserted-by":"publisher","first-page":"16183","DOI":"10.1074\/jbc.M212188200","volume":"278","author":"I Viard-Leveugle","year":"2003","unstructured":"Viard-Leveugle I, Bullani RR, Meda P, Micheau O, Limat A, Saurat JH, Tschopp J, French LE (2003) Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J Biol Chem 278(18):16183\u201316188","journal-title":"J Biol Chem"},{"issue":"3","key":"540_CR61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0091-6749(03)01624-5","volume":"112","author":"Y Teraki","year":"2003","unstructured":"Teraki Y, Shiohara T (2003) IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption. J Allergy Clin Immunol 112(3):609\u2013615","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"540_CR62","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jaci.2012.08.042","volume":"131","author":"Y Teraki","year":"2013","unstructured":"Teraki Y, Kawabe M, Izaki S (2013) Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis. J Allergy Clin Immunol 131(3):907\u2013909. doi:10.1016\/j.jaci.2012.08.042","journal-title":"J Allergy Clin Immunol"},{"issue":"7559","key":"540_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14452","volume":"523","author":"N Gagliani","year":"2015","unstructured":"Gagliani N, Vesely MC, Iseppon A, Brockmann L, Xu H, Palm NW, de Zoete MR, Licona-Limon P, Paiva RS, Ching T, Weaver C, Zi X, Pan X, Fan R, Garmire LX, Cotton MJ, Drier Y, Bernstein B, Geginat J, Stockinger B, Esplugues E, Huber S, Flavell RA (2015) Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523(7559):221\u2013225. doi:10.1038\/nature14452","journal-title":"Nature"},{"issue":"12","key":"540_CR64","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/j.1365-4632.2011.05007.x","volume":"50","author":"CC Ang","year":"2011","unstructured":"Ang CC, Tay YK (2011) Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Int J Dermatol 50(12):1570\u20131578. doi:10.1111\/j.1365-4632.2011.05007.x","journal-title":"Int J Dermatol"},{"key":"540_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12423","author":"SJ Barron","year":"2014","unstructured":"Barron SJ, Del Vecchio MT, Aronoff SC (2014) Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies. Int J Dermatol. doi:10.1111\/ijd.12423","journal-title":"Int J Dermatol"},{"issue":"1","key":"540_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/ijd.12423","volume":"54","author":"SJ Barron","year":"2015","unstructured":"Barron SJ, Del Vecchio MT, Aronoff SC (2015) Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies. Int J Dermatol 54(1):108\u2013115. doi:10.1111\/ijd.12423","journal-title":"Int J Dermatol"},{"issue":"2","key":"540_CR67","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","volume":"167","author":"YC Huang","year":"2012","unstructured":"Huang YC, Li YC, Chen TJ (2012) The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. Br J Dermatol 167(2):424\u2013432. doi:10.1111\/j.1365-2133.2012.10965.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"540_CR68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archderm.139.1.26","volume":"139","author":"C Prins","year":"2003","unstructured":"Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K, Trent J, Margolis DJ, Saurat JH, French LE (2003) Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 139(1):26\u201332","journal-title":"Arch Dermatol"},{"issue":"4","key":"540_CR69","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","volume":"163","author":"L Valeyrie-Allanore","year":"2010","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Maitre B, Revuz J, Bagot M, Roujeau JC (2010) Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 163(4):847\u2013853. doi:10.1111\/j.1365-2133.2010.09863.x","journal-title":"Br J Dermatol"},{"issue":"5","key":"540_CR70","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","volume":"71","author":"MG Kirchhof","year":"2014","unstructured":"Kirchhof MG, Miliszewski MA, Sikora S, Papp A, Dutz JP (2014) Retrospective review of Stevens-Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. J Am Acad Dermatol 71(5):941\u2013947. doi:10.1016\/j.jaad.2014.07.016","journal-title":"J Am Acad Dermatol"},{"issue":"1-2","key":"540_CR71","first-page":"37","volume":"107","author":"C Beylot","year":"1980","unstructured":"Beylot C, Bioulac P, Doutre MS (1980) Acute generalized exanthematic pustuloses (four cases) (author\u2019s transl). Ann Dermatol Venereol 107(1-2):37\u201348","journal-title":"Ann Dermatol Venereol"},{"key":"540_CR72","first-page":"S38","volume":"122","author":"P Bernard","year":"1995","unstructured":"Bernard P, Lizeaux-Parneix V, Miossec V et al (1995) HLA et pr\u00e9disposition g\u00e9n\u00e9tique dans les pustuloses exanth\u00e9matiques (PEAG) et les exanth\u00e9mes maculo-papuleux (EMP). Ann Dermatol Venerol 122:S38\u2013S39","journal-title":"Ann Dermatol Venerol"},{"issue":"3","key":"540_CR73","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","volume":"28","author":"A Sidoroff","year":"2001","unstructured":"Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC (2001) Acute generalized exanthematous pustulosis (AGEP)\u2014a clinical reaction pattern. J Cutan Pathol 28(3):113\u2013119","journal-title":"J Cutan Pathol"},{"issue":"9","key":"540_CR74","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","volume":"127","author":"JC Roujeau","year":"1991","unstructured":"Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin P, Claudy A, Delavierre C, Vaillant L et al (1991) Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 127(9):1333\u20131338","journal-title":"Arch Dermatol"},{"issue":"6-7","key":"540_CR75","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1503\/cmaj.090137","volume":"181","author":"MA Leclair","year":"2009","unstructured":"Leclair MA, Maynard B, St-Pierre C (2009) Acute generalized exanthematous pustulosis with severe organ dysfunction. CMAJ 181(6-7):393\u2013396. doi:10.1503\/cmaj.090137","journal-title":"CMAJ"},{"issue":"4","key":"540_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00130832-200208000-00006","volume":"2","author":"M Britschgi","year":"2002","unstructured":"Britschgi M, Pichler WJ (2002) Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2(4):325\u2013331","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"12","key":"540_CR77","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1002\/art.30565","volume":"63","author":"M Stenerson","year":"2011","unstructured":"Stenerson M, Dufendach K, Aksentijevich I, Brady J, Austin J, Reed AM (2011) The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum 63(12):4018\u20134022. doi:10.1002\/art.30565","journal-title":"Arthritis Rheum"},{"issue":"7","key":"540_CR78","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/jid.2013.44","volume":"133","author":"AA Navarini","year":"2013","unstructured":"Navarini AA, Valeyrie-Allanore L, Setta-Kaffetzi N, Barker JN, Capon F, Creamer D, Roujeau JC, Sekula P, Simpson MA, Trembath RC, Mockenhaupt M, Smith CH (2013) Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis. J Invest Dermatol 133(7):1904\u20131907. doi:10.1038\/jid.2013.44","journal-title":"J Invest Dermatol"},{"issue":"2","key":"540_CR79","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jaci.2011.07.033","volume":"129","author":"S Tresch","year":"2012","unstructured":"Tresch S, Cozzio A, Kamarashev J, Harr T, Schmid-Grendelmeier P, French LE, Feldmeyer L (2012) T cell-mediated acute localized exanthematous pustulosis caused by finasteride. J Allergy Clin Immunol 129(2):589\u2013594. doi:10.1016\/j.jaci.2011.07.033","journal-title":"J Allergy Clin Immunol"},{"key":"540_CR80","doi-asserted-by":"crossref","unstructured":"Tetsuo Shiohara YK, Ryo Takahashi, Tadashi Ishida and Yoshiko Mizukawa (2012) Adverse cutaneous drug eruptions. In: LE F (ed) Drug-induced hypersensitivity syndrome (DIHS\/DRESS): Recent advances in the diagnosis, pathogenesis and management, vol 1. Karger, Basel, pp 122-135","DOI":"10.1159\/000335624"},{"key":"540_CR81","doi-asserted-by":"publisher","first-page":"pp 251","DOI":"10.1159\/000104205","volume-title":"Drug-induced hypersensitivity syndrome and viral reactivation","author":"TTR Shiohara","year":"2007","unstructured":"Shiohara TTR, Kano Y (2007) Drug hypersensitivity. In: Pichler W (ed) Drug-induced hypersensitivity syndrome and viral reactivation, vol 1. Karger, Basel, pp pp 251\u2013266"},{"issue":"7","key":"540_CR82","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","volume":"124","author":"P Cacoub","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC (2011) The DRESS syndrome: a literature review. Am J Med 124(7):588\u2013597. doi:10.1016\/j.amjmed.2011.01.017","journal-title":"Am J Med"},{"issue":"12","key":"540_CR83","doi-asserted-by":"publisher","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","volume":"182","author":"R Takahashi","year":"2009","unstructured":"Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T (2009) Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 182(12):8071\u20138079. doi:10.4049\/jimmunol.0804002","journal-title":"J Immunol"},{"key":"540_CR84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1126\/scitranslmed.3001116","volume":"2","author":"D Picard","year":"2010","unstructured":"Picard D, Janela B, Descamps V, D\u2019Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P (2010) Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2:46\u201346ra62. doi:10.1126\/scitranslmed.3001116","journal-title":"Sci Transl Med"},{"issue":"3","key":"540_CR85","first-page":"301","volume":"137","author":"V Descamps","year":"2001","unstructured":"Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, Belaich S, Crickx B (2001) Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 137(3):301\u2013304","journal-title":"Arch Dermatol"},{"issue":"9","key":"540_CR86","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","volume":"134","author":"Y Suzuki","year":"1998","unstructured":"Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T (1998) Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 134(9):1108\u20131112","journal-title":"Arch Dermatol"},{"issue":"5","key":"540_CR87","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","volume":"156","author":"T Shiohara","year":"2007","unstructured":"Shiohara T, Iijima M, Ikezawa Z, Hashimoto K (2007) The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156(5):1083\u20131084. doi:10.1111\/j.1365-2133.2007.07807.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"540_CR88","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","volume":"155","author":"Y Kano","year":"2006","unstructured":"Kano Y, Hiraharas K, Sakuma K, Shiohara T (2006) Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 155(2):301\u2013306. doi:10.1111\/j.1365-2133.2006.07238.x","journal-title":"Br J Dermatol"},{"issue":"5","key":"540_CR89","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1046\/j.1365-2133.2003.05330.x","volume":"148","author":"V Descamps","year":"2003","unstructured":"Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, Crickx B (2003) Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 148(5):1032\u20131034","journal-title":"Br J Dermatol"},{"issue":"3","key":"540_CR90","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jcv.2009.08.006","volume":"46","author":"L Mardivirin","year":"2009","unstructured":"Mardivirin L, Descamps V, Lacroix A, Delebassee S, Ranger-Rogez S (2009) Early effects of drugs responsible for DRESS on HHV-6 replication in vitro. J Clin Virol: Off Publ Pan Am Soc Clin Virol 46(3):300\u2013302. doi:10.1016\/j.jcv.2009.08.006","journal-title":"J Clin Virol: Off Publ Pan Am Soc Clin Virol"},{"issue":"1","key":"540_CR91","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","volume":"81","author":"V Descamps","year":"2014","unstructured":"Descamps V, Ranger-Rogez S (2014) DRESS syndrome. Joint Bone Spine: Revue Rhum 81(1):15\u201321. doi:10.1016\/j.jbspin.2013.05.002","journal-title":"Joint Bone Spine: Revue Rhum"},{"key":"540_CR92","first-page":"79","volume-title":"Adverse cutaneous drug eruptions","author":"AJ Bircher","year":"2011","unstructured":"Bircher AJ (2011) Uncomplicated drug-induced disseminated exanthemas. In: French L (ed) Adverse cutaneous drug eruptions, vol 1. Karger, Basel, pp 79\u201396"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00281-015-0540-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0540-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:18:56Z","timestamp":1659111536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00281-015-0540-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1007\/s00281-015-0540-2","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,9]]},"assertion":[{"value":"19 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}